Clinical Scorecard: RA App Overestimates Active Disease
At a Glance
| Category | Detail |
|---|---|
| Condition | |
| Key Mechanisms | Patient-derived joint counts may confirm low disease activity or remission but are less reliable for identifying active disease. |
| Target Population | |
| Care Setting |
Key Highlights
- Smartphone app showed modest agreement with physician joint counts.
- Patient-reported assessments had high positive predictive value for low disease activity (95%) but limited sensitivity (54%) and negative predictive value (50%) for detecting active disease.
- Patients reported higher joint counts than physicians, especially for swollen joints.
- Modest agreement may reflect real-world differences and comorbid conditions.
Guideline-Based Recommendations
Diagnosis
- Use physician assessments as primary predictors of disease activity.
- Incorporate in-person assessments to enhance accuracy.
Management
- Consider patient-derived counts for confirming low disease activity or remission.
Monitoring & Follow-up
- Regularly assess both patient-reported and physician-assessed joint counts.
Risks
- Overestimation of active disease due to reliance on patient-reported data.
Patient & Prescribing Data
App-based assessments may not accurately reflect disease activity in cases with poor control.
Clinical Best Practices
- Incorporate both patient-reported and physician assessments in disease monitoring.
- Provide in-person or video instruction to enhance app-based training.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
